4.57
price down icon2.97%   -0.14
pre-market  プレマーケット:  4.73   0.16   +3.50%
loading
前日終値:
$4.71
開ける:
$4.9
24時間の取引高:
833.48K
Relative Volume:
0.74
時価総額:
$290.48M
収益:
$157.08M
当期純損益:
$-70.36M
株価収益率:
-4.1112
EPS:
-1.1116
ネットキャッシュフロー:
$-71.69M
1週間 パフォーマンス:
-5.97%
1か月 パフォーマンス:
+16.88%
6か月 パフォーマンス:
+168.82%
1年 パフォーマンス:
+213.01%
1日の値動き範囲:
Value
$4.565
$5.06
1週間の範囲:
Value
$4.495
$5.06
52週間の値動き範囲:
Value
$1.29
$5.08

Macrogenics Inc Stock (MGNX) Company Profile

Name
名前
Macrogenics Inc
Name
セクター
Healthcare (1100)
Name
電話
301-251-5172
Name
住所
9704 MEDICAL CENTER DRIVE, Rockville, MD
Name
職員
293
Name
Twitter
@macrogenics
Name
次回の収益日
2026-08-13
Name
最新のSEC提出書
Name
MGNX's Discussions on Twitter

Compare MGNX vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
MGNX icon
MGNX
Macrogenics Inc
4.57 293.66M 157.08M -70.36M -71.69M -1.1116
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
529.59 126.07B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
649.81 65.37B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
916.80 57.70B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
313.04 40.19B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
189.99 39.82B 742.00K -1.37B -1.07B -7.0731

Macrogenics Inc Stock (MGNX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-10 アップグレード B. Riley Securities Neutral → Buy
2025-09-17 再開されました Barclays Overweight
2024-11-07 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2024-08-01 ダウングレード BTIG Research Buy → Neutral
2024-07-31 ダウングレード B. Riley Securities Buy → Neutral
2024-07-31 ダウングレード Guggenheim Buy → Neutral
2024-05-10 ダウングレード BMO Capital Markets Outperform → Market Perform
2024-05-10 ダウングレード Stifel Buy → Hold
2024-05-10 ダウングレード TD Cowen Buy → Hold
2024-04-26 開始されました B. Riley Securities Buy
2024-04-09 アップグレード TD Cowen Hold → Buy
2024-03-04 繰り返されました BTIG Research Buy
2024-02-14 ダウングレード H.C. Wainwright Buy → Neutral
2023-12-20 アップグレード Citigroup Neutral → Buy
2023-11-07 アップグレード Guggenheim Neutral → Buy
2023-03-17 ダウングレード Guggenheim Buy → Neutral
2022-11-22 ダウングレード Cowen Outperform → Market Perform
2022-11-14 アップグレード BMO Capital Markets Market Perform → Outperform
2022-07-18 ダウングレード SMBC Nikko Outperform → Neutral
2022-07-11 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-05-04 ダウングレード Guggenheim Buy → Neutral
2022-02-28 アップグレード Citigroup Neutral → Buy
2022-02-11 開始されました BMO Capital Markets Outperform
2022-02-04 開始されました SMBC Nikko Outperform
2021-11-17 再開されました Guggenheim Buy
2021-10-19 開始されました JMP Securities Mkt Outperform
2021-10-15 再開されました BTIG Research Buy
2021-04-26 再開されました Credit Suisse Outperform
2021-03-12 アップグレード Barclays Underweight → Overweight
2020-12-22 再開されました H.C. Wainwright Buy
2020-08-03 ダウングレード Citigroup Buy → Neutral
2020-06-01 アップグレード Guggenheim Neutral → Buy
2020-05-26 繰り返されました H.C. Wainwright Buy
2020-03-04 開始されました Barclays Underweight
2019-12-19 開始されました Cantor Fitzgerald Overweight
2019-12-18 開始されました Cantor Fitzgerald Overweight
2019-11-21 ダウングレード Morgan Stanley Equal-Weight → Underweight
2019-11-20 再開されました Guggenheim Neutral
2019-05-03 アップグレード Wedbush Neutral → Outperform
2019-04-12 開始されました Guggenheim Neutral
2019-02-07 アップグレード Citigroup Sell → Buy
2019-02-07 ダウングレード Wedbush Outperform → Neutral
2019-02-06 アップグレード Raymond James Underperform → Mkt Perform
2019-02-04 ダウングレード Citigroup Neutral → Sell
2018-12-10 ダウングレード Raymond James Outperform → Underperform
2018-09-10 再開されました BTIG Research Buy
2018-05-31 開始されました Evercore ISI Outperform
2018-03-05 開始されました H.C. Wainwright Buy
2017-03-31 開始されました Raymond James Outperform
すべてを表示

Macrogenics Inc (MGNX) 最新ニュース

pulisher
Jun 29, 2026

MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 2000 Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 28, 2026

Enterprise value to revenue forward of MacroGenics, Inc. – NASDAQ:MGNX - TradingView

Jun 28, 2026
pulisher
Jun 28, 2026

MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 3000E Value Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Price to earnings forward of MacroGenics, Inc. – NASDAQ:MGNX - TradingView

Jun 28, 2026
pulisher
Jun 28, 2026

Enterprise value to revenue forward of MacroGenics, Inc. – BOATS:MGNX - TradingView

Jun 28, 2026
pulisher
Jun 28, 2026

Enterprise value to EBITDA forward of MacroGenics, Inc. – BOATS:MGNX - TradingView

Jun 28, 2026
pulisher
Jun 28, 2026

Enterprise value to EBIT forward of MacroGenics, Inc. – NASDAQ:MGNX - TradingView

Jun 28, 2026
pulisher
Jun 27, 2026

Enterprise value to EBIT forward of MacroGenics, Inc. – BOATS:MGNX - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Price to sales forward of MacroGenics, Inc. – NASDAQ:MGNX - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Price to book forward of MacroGenics, Inc. – BOATS:MGNX - TradingView

Jun 27, 2026
pulisher
Jun 26, 2026

MGNX Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

MacroGenics, Inc. Actuals & Estimates (NASDAQ:MGNX) - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

M55 Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

A1W6ND Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 24, 2026

MacroGenics Inc (MGNX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 24, 2026
pulisher
Jun 24, 2026

MacroGenics: 'Hold' Potential Best-In-Class B7-H3 ADC And TZIELD Payment (NASDAQ:MGNX) - Seeking Alpha

Jun 24, 2026
pulisher
Jun 23, 2026

MacroGenics To Receive $24.5 Million Milestone From Sanofi For TZIELD Approval - Pulse 2.0

Jun 23, 2026
pulisher
Jun 22, 2026

MacroGenics stock rises on $24.5M Sanofi milestone payment - Investing.com

Jun 22, 2026
pulisher
Jun 22, 2026

MacroGenics to receive $24.5M milestone from Sanofi on FDA approval - Investing.com Australia

Jun 22, 2026
pulisher
Jun 22, 2026

MacroGenics stock rises on $24.5M Sanofi milestone payment By Investing.com - Investing.com Nigeria

Jun 22, 2026
pulisher
Jun 22, 2026

Sanofi (SNY) Drives $24.5M Milestone Payment to MacroGenics - GuruFocus

Jun 22, 2026
pulisher
Jun 22, 2026

MacroGenics to Receive $24.5 Million in Regulatory Milestone Payment - marketscreener.com

Jun 22, 2026
pulisher
Jun 22, 2026

MacroGenics to Receive $24.5 Million Milestone Payment Following FDA Accelerated Approval of Sanofi’s TZIELD for Children with Stage 3 Type 1 Diabetes - Quiver Quantitative

Jun 22, 2026
pulisher
Jun 22, 2026

Sanofi’s TZIELD approval triggers $24.5M payment to MacroGenics - Stock Titan

Jun 22, 2026
pulisher
Jun 19, 2026

MacroGenics (MGNX) Gains 4.3% as Shares Test Key Resistance LevelsOrder Block - dars.gov.et

Jun 19, 2026
pulisher
Jun 18, 2026

MacroGenics Inc (MGNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

MacroGenics StockThursday technical snapshot after strong year-to-date rebound - AD HOC NEWS

Jun 18, 2026
pulisher
Jun 18, 2026

MacroGenics Inc (MGNX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 18, 2026
pulisher
Jun 17, 2026

MacroGenics Inc (MGNX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

MacroGenics Inc (MGNX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

MacroGenics Inc (MGNX) Institutional Confidence - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

MacroGenics Inc (MGNX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

MacroGenics Inc (MGNX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 12, 2026

MacroGenics Inc Stock (US5562221046): Valuation metrics in focus after recent biotech swing - Ad-hoc-news.de

Jun 12, 2026
pulisher
Jun 06, 2026

How The MacroGenics (MGNX) Story Is Shifting With ADC Pipeline Bets And 2026 Data Risks - Yahoo Finance

Jun 06, 2026
pulisher
Jun 05, 2026

Millennium Group and Israel Englander report 3.44M MGNX shares (5.4%) - Stock Titan

Jun 05, 2026
pulisher
May 31, 2026

MacroGenics eyes $200M cash boost, 2028 runway ahead of cancer pipeline updates - MSN

May 31, 2026
pulisher
May 31, 2026

MacroGenics (MGNX) Slips 1.19% as Biotech Stock Tests Key SupportPoint of Control - Město Břeclav

May 31, 2026
pulisher
May 29, 2026

MacroGenics expands ZYNYZ royalty deal with Sagard, secures $60M upfront - MSN

May 29, 2026
pulisher
May 29, 2026

MacroGenics Inc stock (US5562221046): shares ease after strong year-to-date run amid biotech volatil - AD HOC NEWS

May 29, 2026
pulisher
May 28, 2026

Will MacroGenics (MGNX) report negative Q1 earnings? What you should know - MSN

May 28, 2026
pulisher
May 27, 2026

Macrogenics(MGNX) Stock Options Chain | Quotes & News - Moomoo

May 27, 2026
pulisher
May 27, 2026

MacroGenics, Inc. (MGNX) Latest Stock News & Headlines - Yahoo Finance

May 27, 2026
pulisher
May 27, 2026

MacroGenics Eyes $200M Cash Boost, 2028 Runway Ahead of Cancer Pipeline Updates - TradingView

May 27, 2026
pulisher
May 27, 2026

MGNXMacrogenics Inc Stock Price and Quote - Finviz

May 27, 2026
pulisher
May 25, 2026

MacroGenics, Inc. Hits New 52-Week High of $4.64 - Markets Mojo

May 25, 2026
pulisher
May 24, 2026

MacroGenics to sell manufacturing operations to Bora for $122.5M - MSN

May 24, 2026

Macrogenics Inc (MGNX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Macrogenics Inc (MGNX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
HEIDEN WILLIAM K
Director
Aug 19 '25
Buy
1.52
50,500
76,760
61,500
HEIDEN WILLIAM K
Director
Aug 20 '25
Buy
1.49
49,500
73,755
111,000
Koenig Scott
Director
Aug 13 '25
Option Exercise
0.00
52,829
0
830,244
$111.54
price down icon 0.05%
$56.92
price down icon 1.47%
$35.39
price up icon 0.74%
ONC ONC
$309.46
price up icon 3.97%
$81.80
price up icon 2.56%
$189.99
price up icon 0.40%
大文字化:     |  ボリューム (24 時間):